Andreas Stallmach

17.0k total citations · 4 hit papers
418 papers, 10.3k citations indexed

About

Andreas Stallmach is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Andreas Stallmach has authored 418 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 183 papers in Epidemiology, 145 papers in Genetics and 103 papers in Surgery. Recurrent topics in Andreas Stallmach's work include Inflammatory Bowel Disease (134 papers), Microscopic Colitis (116 papers) and Clostridium difficile and Clostridium perfringens research (43 papers). Andreas Stallmach is often cited by papers focused on Inflammatory Bowel Disease (134 papers), Microscopic Colitis (116 papers) and Clostridium difficile and Clostridium perfringens research (43 papers). Andreas Stallmach collaborates with scholars based in Germany, United States and United Kingdom. Andreas Stallmach's co-authors include Tony Bruns, Carsten Schmidt, Martin Zeitz, E O Riecken, Thomas Giese, Philipp A. Reuken, Stefan Hagel, K Lange, Martin J. Buerger and Harald Matthes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Andreas Stallmach

393 papers receiving 10.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression

2004 618 citations Andreas Stallmach et al. Gut profile →
TGF-β and fibrosis in different organs — molecular pathway imprints

2009 513 citations Andreas Stallmach et al. profile →
Effects of Antibiotics on Gut Microbiota

2016 448 citations K Lange, Andreas Stallmach et al. profile →
Long COVID is associated with severe cognitive slowing: a multicentre cross-sectional study

2024 42 citations Philipp A. Reuken, Andreas Stallmach et al. profile →

Peers

Countries citing papers authored by Andreas Stallmach

Since Specialization

Citations

This map shows the geographic impact of Andreas Stallmach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Stallmach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Stallmach more than expected).

Fields of papers citing papers by Andreas Stallmach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Stallmach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Stallmach. The network helps show where Andreas Stallmach may publish in the future.

Co-authorship network of co-authors of Andreas Stallmach

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Stallmach. A scholar is included among the top collaborators of Andreas Stallmach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Stallmach. Andreas Stallmach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	P0885 Therapeutic Concepts for Pyoderma Gangrenosum as an Extraintestinal Manifestation in Chronic Inflammatory Bowel Diseases 2025 ·Journal of Crohn s and Colitis ·(unknown), (unknown), (unknown), Andreas Stallmach, K Lange	0
2	Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent <i>Clostridioides difficile</i> Infection 2024 ·Visceral Medicine ·Johannes Stallhofer, (unknown), (unknown), Andreas Stallmach	4
3	Update des Addendums zu den S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Betreuung von Patienten mit chronisch-entzündlichen Darmerkrankungen in Bezug auf COVID-19 (Version 2.0) 2024 ·Zeitschrift für Gastroenterologie ·Carsten Schmidt, Andreas Stallmach, Andreas Sturm, Oliver Bachmann, Ulf Helwig, Sibylle Koletzko, Petra Lynen, Elisabeth Schnoy, Axel Dignaß, Torsten Kucharzik, Irina Blumenstein, (unknown)	1
4	Web-based telemedicine approach for treatment of post-COVID-19 in Thuringia (WATCH) 2024 ·Digital Health ·Philipp A. Reuken, Bianca Besteher, Jutta Bleidorn, Dirk Brockmann, Kathrin Finke, Antje Freytag, Katja Lehmann, Christina Lemhöfer, Rafael Mikolajczyk, Christian Puta, André Scherag, Marc Wiedermann, Bettina Zippel‐Schultz, Andreas Stallmach	0
5	Towards an understanding of physical activity-induced post-exertional malaise: Insights into microvascular alterations and immunometabolic interactions in post-COVID condition and myalgic encephalomyelitis/chronic fatigue syndrome 2024 ·Infection ·(unknown), Diana Dudziak, Carmen Scheibenbogen, Martina Seifert, Franziska Sotzny, Carsten Finke, Uta Behrends, Konrad Aden, (unknown), Dirk Brockmann, (unknown), Wilhelm Bloch, (unknown), Anuradha Ramoji, Jürgen Popp, Philipp A. Reuken, Martin A. Walter, Andreas Stallmach, Christian Puta	10
6	Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease 2023 ·International Journal of Colorectal Disease ·Johannes Stallhofer, (unknown), Miriam Kesselmeier, Philip Grunert, K Lange, (unknown), (unknown), Andreas Stallmach	9
7	Feasibility studies of multimodal nonlinear endoscopy using multicore fiber bundles for remote scanning from tissue sections to bulk organs 2023 ·Scientific Reports ·(unknown), (unknown), Tobias Meyer‐Zedler, Thomas Bocklitz, (unknown), Bernhard Messerschmidt, Adrian T. Press, Michael Bauer, Orlando Guntinas‐Lichius, Andreas Stallmach, Michael Schmitt, Jürgen Popp	11
8	Review article: Translating STRIDE‐II into clinical reality – Opportunities and challenges 2023 ·Alimentary Pharmacology & Therapeutics ·Axel Dignaß, Stefan Rath, (unknown), Andreas Stallmach	20
9	Immunoadsorption to treat patients with severe post‐COVID syndrome 2023 ·Therapeutic Apheresis and Dialysis ·Benjamin Giszas, Philipp A. Reuken, (unknown), Michael Kiehntopf, (unknown), Silke Rummler, Andreas Stallmach, (unknown)	6
10	Longterm course of neuropsychological symptoms and ME/CFS after SARS-CoV-2-infection: a prospective registry study 2023 ·European Archives of Psychiatry and Clinical Neuroscience ·Philipp A. Reuken, Bianca Besteher, Kathrin Finke, Andrea Fischer, Alexander Höll, (unknown), Katja Lehmann, Christina Lemhöfer, (unknown), Christian Puta, Martin A. Walter, Christine Weißenborn, Andreas Stallmach	13
11	Early ribavirin for hepatitis E virus infection in patients receiving immunosuppressive therapy: a retrospective, observational study 2023 ·Journal of International Medical Research ·(unknown), Philipp A. Reuken, (unknown), Michael Rose, Katharina Boden, Andreas Stallmach, Tony Bruns	3
12	Recurrent Disseminated Intravascular Coagulation in Metastatic Castration-Resistant Prostate Cancer: A Case Report 2022 ·Diagnostics ·Benjamin Giszas, (unknown), Marc‐Oliver Grimm, Andreas Stallmach, Philipp A. Reuken	1
13	Mobile primary healthcare for post-COVID patients in rural areas: a proof-of-concept study 2022 ·Infection ·Andreas Stallmach, (unknown), Bianca Besteher, Kathrin Finke, Benjamin Giszas, (unknown), (unknown), Katja Lehmann, (unknown), (unknown), (unknown), (unknown), (unknown), Christian Puta, (unknown), Philipp A. Reuken	10
14	Acceptance of SARS-CoV-2 vaccines by liver transplant recipients and candidates 2021 ·Zeitschrift für Gastroenterologie ·Philipp A. Reuken, Stefanie Albers, Falk Rauchfuß, Pavel Strnad, Utz Settmacher, Christian Trautwein, Andreas Stallmach, Tony Bruns	3
15	Self-assessment of treatment targets in patients with inflammatory bowel disease using a survey 2020 ·Therapeutic Advances in Gastroenterology ·Philipp A. Reuken, Philip Grunert, Andreas Lügering, Niels Teich, Andreas Stallmach	3
16	Thumb sucking or nail biting in childhood and adolescence is associated with an increased risk of Crohn’s disease: results from a large case–control study 2020 ·Scandinavian Journal of Gastroenterology ·Niels Teich, Wolfgang Mohl, Christian Primas, Gottfried Novacek, Annika Gauss, Jens Walldorf, G Felten, Raja Atreya, Wolfgang Kruis, Dominik Bettenworth, (unknown), Jost Langhorst, Karen M. Schmidt, Tony Bruns, Andreas Stallmach, (unknown)	4
17	Transcriptional Suppression of the NLRP3 Inflammasome and Cytokine Release in Primary Macrophages by Low-Dose Anthracyclines 2019 ·Cells ·(unknown), Sven Stengel, (unknown), (unknown), Philipp A. Reuken, Andreas Stallmach, Tony Bruns	7
18	The prognostic significance of bacterial DNA in patients with decompensated cirrhosis and suspected infection 2016 ·Liver International ·Tony Bruns, Philipp A. Reuken, Sven Stengel, Ludmila Gerber, Beate Appenrodt, (unknown), Frank Lammert, Stefan Zeuzem, Andreas Stallmach	34
19	Remission of refractory C rohn's disease by high‐dose cyclophosphamide and autologous peripheral blood stem cell transplantation 2012 ·Alimentary Pharmacology & Therapeutics ·Peter Hasselblatt, (unknown), Karin Potthoff, Hartmut Bertz, Wolfgang Kruis, Carsten Schmidt, Andreas Stallmach, Annette Schmitt‐Graeff, Jürgen Finke, Wolfgang Kreisel	45
20	Differentiation of rat intestinal epithelial cells is induced by organotypic mesenchymal cells in vitro. 1989 ·Gut ·Andreas Stallmach, Ursula Hahn, H.-J. Merker, Eckhart G. Hahn, E O Riecken	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact